Condition: AIS · Sponsor: Biocells (Beijing) Biotech Co.,Ltd
The purpose of this study was to evaluate the efficacy of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke
This description comes directly from the study's public registry record.
ming xiao zhang · +86 15910367860 · zhangxiaoming@biocells.cn
Always discuss trial participation with your own doctor first.
| Harrison International Peace Hospital | Hengshui, Hebei, China | Recruiting |
| Daqing Oilfield General Hospital | Daqing, Heilongjiang, China | Recruiting |
| The First Affiliated Hospital of Nanyang Medicinal College | Nanyang, Henan, China | Recruiting |
| MeiHekou Central Hospital | Meihekou, Jilin, China | Recruiting |
| The Affiliated Hospital of Shenyang Medical College | Shenyang, Liaoning, China | Recruiting |
| Xianyang Hospital of Yan'an University | Xianyang, Shaanxi, China | Recruiting |
| Linyi People's Hospital | Linyi, Shandong, China | Recruiting |
| Linfen Central Hospital | Linfen, Shanxi, China | Not Yet Recruiting |
| Beijing Tiantan Hospital , Capital Medical University | Beijing, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07520565